SQUARE PHARMA KENYA Launches Bactoken® (Mupirocin 2% USP) Ointment (19 November, 2025)
SQUARE PHARMA KENYA proudly announced the official launch of Bactoken® (Mupirocin 2% USP) Ointment, a topical antibiotic for effective treatment of bacterial skin infections. The launch event was held at the prestigious Sarova Panafric Hotel, in presence of an impressive gathering of 160 HCPs of Kenya.
During the event, medical experts and senior representatives from SQUARE discussed the therapeutic benefits, safety profile, and clinical relevance of Backtoken® (Mupirocin 2% USP) Ointment in daily practice. The launch program strengthened collaboration with Kenyan healthcare professionals and demonstrated the company’s ongoing dedication to delivering world-class pharmaceutical solutions.
During the event, medical experts and senior representatives from SQUARE discussed the therapeutic benefits, safety profile, and clinical relevance of Backtoken® (Mupirocin 2% USP) Ointment in daily practice. The launch program strengthened collaboration with Kenyan healthcare professionals and demonstrated the company’s ongoing dedication to delivering world-class pharmaceutical solutions.
